U.S. Markets closed

Omnicell, Inc. (OMCL)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
43.2000+0.0500 (+0.1159%)
At close: 4:00PM EDT
People also watch
OFIXABAXCPSIBABYHMSY

Omnicell, Inc.

590 East Middlefield Road
Mountain View, CA 94043
United States
650-251-6100
http://www.omnicell.com

SectorTechnology
IndustryHealthcare Information Services
Full Time Employees2,361

Key Executives

NameTitlePayExercisedAge
Mr. Randall A. LippsFounder, Exec. Chairman, Chief Exec. Officer and Pres1.27MN/A60
Mr. Peter J. KuipersChief Financial Officer and Exec. VP528.42kN/A45
Mr. Nhat H. NgoExec. VP of Strategy and Bus. Devel.485.91kN/A44
Mr. J. Christopher DrewPres of North American Automation and Analytics570.03k928.78k51
Mr. Robin G. SeimPres of Global Automation and Medication Adherence581.59k125.84k57
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems. The company also provides OmniLinkRx, a prescription routing system; WorkflowRx, an automated pharmacy storage, retrieval, and packaging system; Central and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; and Anesthesia Workstation that manages anesthesia supplies and medications. In addition, it offers Omnicell Supply Management System, which automates the management and dispensing of medical and surgical supplies; Omnicell Tissue Center, which manages the chain of custody for bone and tissue specimens; OptiFlex MS that manages medical and surgical supplies; OptiFlex SS, a module for the perioperative areas; OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas. Further, Omnicell, Inc. offers Mach4 Pharma Systems Medimat, a robotic dispensing system for handling the stocking and retrieval of medications; IV Solutions; software; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.

Corporate Governance

Omnicell, Inc.’s ISS Governance QualityScore as of July 1, 2017 is 4. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.